Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z-S Chen

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Recent Patents on Anti-Cancer Drug Discovery|March 8, 2018
TC > 0.05 as a Pharmacokinetic Parameter of Paclitaxel for Therapeutic Efficacy and Toxicity in Cancer PatientsD S Xin, L Zhou, C Z Li, et al.
Zhonghua Yi Xue Za Zhi|August 17, 2023
[Efficacy and prognosis of infant kidney transplantation]L Zhu, Z L Guo, D D Zhao, et al.
The Journal of Infectious Diseases|March 5, 2010
Local hyperthermia at 44 degrees C for the treatment of plantar warts: a randomized, patient-blinded, placebo-controlled trialWei Huo, Xing-Hua Gao, Xiu-Ping Sun, et al.
Zhonghua Yi Xue Za Zhi|January 26, 2025
[Analysis of outcomes in adult deceased donor dual kidney transplantation]D D Zhao, L M Zhang, N Q Gong, et al.
Zhonghua Yi Xue Za Zhi|January 17, 2017
[Risk factors for acute rejection in living-donor kidney transplant recipients in China: a subgroup analysis of a multi-center, registry study]X P Hu, Y Tian, T Y Zhu, et al.
The Journal of Investigative Dermatology|February 18, 2011
BRAF exon 15 T1799A mutation is common in melanocytic nevi, but less prevalent in cutaneous malignant melanoma, in Chinese HanRui-Qun Qi, Li He, Song Zheng, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Recent Patents on Anti-Cancer Drug Discovery|March 8, 2018
TC > 0.05 as a Pharmacokinetic Parameter of Paclitaxel for Therapeutic Efficacy and Toxicity in Cancer PatientsD S Xin, L Zhou, C Z Li, et al.
Zhonghua Yi Xue Za Zhi|August 17, 2023
[Efficacy and prognosis of infant kidney transplantation]L Zhu, Z L Guo, D D Zhao, et al.
The Journal of Infectious Diseases|March 5, 2010
Local hyperthermia at 44 degrees C for the treatment of plantar warts: a randomized, patient-blinded, placebo-controlled trialWei Huo, Xing-Hua Gao, Xiu-Ping Sun, et al.
Zhonghua Yi Xue Za Zhi|January 26, 2025
[Analysis of outcomes in adult deceased donor dual kidney transplantation]D D Zhao, L M Zhang, N Q Gong, et al.
Zhonghua Yi Xue Za Zhi|January 17, 2017
[Risk factors for acute rejection in living-donor kidney transplant recipients in China: a subgroup analysis of a multi-center, registry study]X P Hu, Y Tian, T Y Zhu, et al.
The Journal of Investigative Dermatology|February 18, 2011
BRAF exon 15 T1799A mutation is common in melanocytic nevi, but less prevalent in cutaneous malignant melanoma, in Chinese HanRui-Qun Qi, Li He, Song Zheng, et al.
Pageof 8